Abliva AB (ABLI) NPV
Sell:0.16 SEK
Buy:0.16 SEK
Change:
0.0026 SEK
(1.60%)
0.0026 SEK
(1.60%)
- Add to watchlist
- This stock can be held in a
Sell:0.16 SEK
Buy:0.16 SEK
Change:
0.0026 SEK
(1.60%)
0.0026 SEK
(1.60%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Sell:0.16 SEK
Buy:0.16 SEK
Change:
0.0026 SEK
(1.60%)
0.0026 SEK
(1.60%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Business summary
Abliva AB is a Sweden-based company involved in pharmaceutical industry. The Company focuses on the development of novel treatments for primary mitochondrial diseases.
Contact details
Important dates
General stock information
- Short code:
- ABLI
- ISIN:
- SE0002575340
- Market cap:
- 217.79 million SEK
- Shares in issue:
- 1.06 billion
- Sector:
- Biotechnology
- Exchange:
- Stockholm Stock Exchange
- Country:
- Sweden
- Currency:
- Swedish Krona
- Indices:
- n/a
Key personnel
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd.
General stock information provided by Reuters.
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.